Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
56.91 USD | +0.55% | -2.27% | -1.09% |
Apr. 24 | Andersons Insider Sold Shares Worth $531,429, According to a Recent SEC Filing | MT |
Mar. 01 | BACKGROUND/Capital Markets Day at Bayer: To split up or not? | DP |
Financials (USD)
Sales 2024 * | 13.47B | Sales 2025 * | 13.73B | Capitalization | 1.91B |
---|---|---|---|---|---|
Net income 2024 * | 87M | Net income 2025 * | 110M | EV / Sales 2024 * | 0.14 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 0.14 x |
P/E ratio 2024 * |
22.3
x | P/E ratio 2025 * |
17.6
x | Employees | 2,259 |
Yield 2024 * |
1.34% | Yield 2025 * |
1.38% | Free-Float | 94.24% |
Latest transcript on The Andersons, Inc.
1 day | -1.36% | ||
1 week | +0.35% | ||
Current month | -1.34% | ||
1 month | -0.04% | ||
3 months | +8.70% | ||
6 months | +15.06% | ||
Current year | -1.63% |
Managers | Title | Age | Since |
---|---|---|---|
Patrick Bowe
CEO | Chief Executive Officer | 65 | 15-11-01 |
Brian Valentine
DFI | Director of Finance/CFO | 54 | 18-07-31 |
Michael Anderson
CHM | Chairman | 72 | 87-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Robert King
BRD | Director/Board Member | 68 | 05-07-28 |
Director/Board Member | 60 | 07-11-30 | |
Michael Anderson
CHM | Chairman | 72 | 87-12-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.20% | 45 M€ | -0.39% |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 56.91 | +0.55% | 152 469 |
24-04-25 | 56.6 | -1.36% | 183,204 |
24-04-24 | 57.38 | -5.02% | 287,061 |
24-04-23 | 60.41 | +2.48% | 299,564 |
24-04-22 | 58.95 | +1.24% | 238,540 |
Delayed Quote Nasdaq, April 25, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-1.63% | 1.91B | |
+3.85% | 1.36B | |
-14.99% | 995M | |
-10.60% | 995M | |
-10.02% | 972M | |
-16.84% | 875M | |
+10.38% | 735M | |
-4.63% | 430M | |
-66.86% | 357M | |
+44.26% | 315M |
- Stock Market
- Equities
- ANDE Stock